InvestorsHub Logo

TheDane

01/26/22 7:56 AM

#387501 RE: farrell90 #387495

20 cents on the way.

loanranger

01/26/22 8:09 AM

#387502 RE: farrell90 #387495

"Could the promise of an update on Brilacidin in Covid 19 be in regards to the inclusion of Brilacidin in the NIH's fully funded ACTIV trial for Covid19 therapeutics?"

Which of the ACTIV trial protocols would you think B might find a place in?
https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials

Could the NIH be expected to fund B's inclusion in a trial given the recent reported results? Or are you relying on the results still to be reported to justify or, as you imply with your question, have already justified interest on their part?

"You have to decide for yourself."
No kidding.